Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro

Reyes, M., Filbin, M. R., Bhattacharyya, R. P., Sonny, A., Mehta, A., Billman, K., Kays, K. R., Pinilla-Vera, M., Benson, M. E., Cosimi, L. A., Hung, D. T., Levy, B. D., Villani, A., Sade-Feldman, M., Baron, R. M., Goldberg, M. B., Blainey, P. C. and Hacohen, N.  Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.  Science Translational Medicine. 2021; 13(598), eabe9599.  doi: 10.1126/scitranslmed.abe9599

Privacy Preference Center

Necessary

Advertising

Analytics

Other